Risk of myopericarditis following COVID-19 vaccination is very low, confirms study

The overall risk of myopericarditis following COVID-19 vaccination is very low, affecting 18 people per million vaccine doses. A new study published in The Lancet Respiratory Medicine, confirms that this risk is comparable to or lower following COVID-19 vaccination than other non-COVID-19 vaccines.

Related Keywords

National University Hospital ,Singapore General ,Singapore ,United States ,Kollengode Ramanathan ,Margaret Ryan ,Jyoti Somani ,Emily Henderson ,University Of California San Diego ,Defence Health Agency ,Lancet Respiratory Medicine ,Study Corresponding Author ,Cardiac Intensivist ,National University ,Clinical Professor ,California San Diego ,Covid 19 ,Medicine ,Espiratory ,Heart ,Hospital ,Inflammation ,Influenza ,Pandemic ,Research ,Smallpox ,Vaccine ,